NORTHVALE, NJ / ACCESSWIRE / May 2, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT) today issued the following investor update:
March 31, 2018 marked the completion of ADMT's fiscal year. It also marked the planned inception of the Company's new business model - to re-position ADMT as a developer of its own "brand name" medical technologies. Management is thankful for the combined efforts of its Medical Device Engineering Services division and Aqua Based Technologies division for generating record revenues and profits over the past three years. These revenues and profits were then invested in the Company's future success, allowing it to develop its own suite of disruptive medical technologies, which are planned to be launched over the next twelve months. Management anticipates that the success of any one of these new medical technologies could be responsible for dramatic growth in company revenues. Additionally, management believes that one or more of ADMT's technologies has the potential to become a standard of care for certain medical protocols.
This planned strategy by management puts ADMT competing directly in the field of medical technology. ADMT possesses a forward thinking, multidisciplinary staff of medical technology engineers and technologists, the latest R&D and manufacturing equipment, plus an FDA compliance department with an outstanding record of regulatory expertise, essential for launching new medical technologies in the US and worldwide.
Andre' DiMino, CEO of ADMT commented, "Our efforts have not gone unnoticed." ADMT has been featured in medical and technology publications, most recently ADMT was profiled in the April 15 edition of Embedded Advisor Magazine as one of the Top 20 Medical Devices Design & Solution Provider for 2018 (embeddedadvisor.com). In addition, ADMT subsidiary Aurex International's first product, Tinnitus & Hearing Shield, has garnered attention in the industry such as on Health Tech Insider - https://healthtechinsider.com/2018/02/21/new-earplug-promises-tinnitus-protection/
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services and Eco-Friendly, Safe, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered medical device and manufacturing operations are located in NJ, Northvale . ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D solid prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are "forward looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact: Andre' DiMino 201-767-6040, firstname.lastname@example.org
SOURCE: ADM Tronics Unlimited, Inc.